Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
EBIATLong-Term Debt IssuancesShares IssuedShares OutstandingShort-Term Debt issuancesWages, Salaries and Other
Ratios

Regen BioPharma (RGBP) Long-Term Debt Repayments (2023 - 2024)

Historic Long-Term Debt Repayments for Regen BioPharma (RGBP) over the last 2 years, with Q4 2024 value amounting to $65799.0.

  • Regen BioPharma's Long-Term Debt Repayments rose 24150.32% to $65799.0 in Q4 2024 from the same period last year, while for Dec 2025 it was $65799.0, marking a year-over-year decrease of 3567.97%. This contributed to the annual value of $194599.0 for FY2025, which is 204599.0% up from last year.
  • Per Regen BioPharma's latest filing, its Long-Term Debt Repayments stood at $65799.0 for Q4 2024, which was up 24150.32% from $36500.0 recorded in Q1 2024.
  • Over the past 5 years, Regen BioPharma's Long-Term Debt Repayments peaked at $65799.0 during Q4 2024, and registered a low of -$46500.0 during Q4 2023.